• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. European Medicines Agency’s CHMP Recommends Approval of Merck ’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    European Medicines Agency’s CHMP Recommends Approval of Merck ’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

  2. Trumpcare's collapse creates some certainty for health-care stocks

    Trumpcare's collapse creates some certainty for health-care stocks

  3. UPDATE: Trumpcare's collapse creates some certainty for health-care stocks

    UPDATE: Trumpcare's collapse creates some certainty for health-care stocks

  4. UPDATE: Trumpcare's collapse creates some certainty for health-care stocks

    UPDATE: Trumpcare's collapse creates some certainty for health-care stocks

  5. Merck Provides Update on Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in Previously Treated Advanced Microsatellite Instability-High Cancer

    Merck Provides Update on Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in Previously Treated Advanced Microsatellite Instability-High Cancer

  6. Merck's Fourth-Quarter Net Profit Soars to EUR269 Million

    Merck's Fourth-Quarter Net Profit Soars to EUR269 Million

  7. Top 5 Vendors in the Global Bovine Respiratory Disease Treatment Market from 2017-2021: Technavio

    Top 5 Vendors in the Global Bovine Respiratory Disease Treatment Market from 2017-2021: Technavio

  8. TransCelerate Identifies Pharmacovigilance as an Operational Challenge in Need of Transformation

    TransCelerate Identifies Pharmacovigilance as an Operational Challenge in Need of Transformation

  9. PTFE Membrane Market to Reach $2.32 Billion by 2021 - Increasing Demand for PTFE Membrane in the Medical & Pharmaceutical Industry - Research and Markets

    PTFE Membrane Market to Reach $2.32 Billion by 2021 - Increasing Demand for PTFE Membrane in the Medical & Pharmaceutical Industry - Research and Markets

  10. Evotec Fiscal Year Results 2016: Leading Innovation Efficiency & First-in-Class Drug Discovery

    Evotec Fiscal Year Results 2016: Leading Innovation Efficiency & First-in-Class Drug Discovery

12345

©2017 Morningstar Advisor. All right reserved.